Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results

2017221 citationsJournal Articlegold Open Access

Authors

ClinicalTrials.gov NCT00375674.

Good health and well-being

Published in: European Urology

Volume 73, Issue 1, pp. 62-68

Field-Weighted Citation Impact: 15.33